Skip to main content

Table 2 a-c Regression models predicting reserve-related activitiesa

From: Reserve-related activities and MRI metrics in multiple sclerosis patients and healthy controls: an observational study

Dependent Variable:

           

2a Past Reserve Building Activities

2b Strenuous Current reserve-related Activities

2c Non-Strenuous Current reserve-related Activities

Predictors

β

t

p

Predictors

β

t

p

Predictors

β

t

p

Chronic lesion burden models

 Age

0.01

0.13

0.90

Age

–0.19

–3.94

0.00

Age

–0.05

–0.94

0.35

 Gender

–0.02

–0.42

0.68

Gender

–0.07

–1.72

0.09

Gender

–0.05

–1.07

0.29

 Chronic Burden

–0.31

–1.25

0.21

Chronic Burden

–0.34

–1.46

0.15

Chronic Burden

0.20

0.82

0.41

 CIS

0.01

0.08

0.94

CIS

–0.37

–5.04

0.00

CIS

–0.03

–0.43

0.67

 RR

–0.03

–0.24

0.81

RR

–0.51

–5.33

0.00

RR

0.09

0.87

0.38

 PMS

–0.14

–1.37

0.17

PMS

–0.51

–5.42

0.00

PMS

0.13

1.32

0.19

 Chronic X CIS

0.01

0.18

0.86

Chronic X CIS

0.15

2.58

0.01

Chronic X CIS

0.06

1.05

0.29

 Chronic X RR

0.17

0.85

0.39

Chronic X RR

0.26

1.41

0.16

Chronic X RR

–0.14

–0.70

0.49

 Chronic X SPMS

0.30

1.42

0.16

Chronic X SPMS

0.30

1.51

0.13

Chronic X SPMS

–0.17

–0.83

0.41

 Adjusted R-squared

0.00

  

Adjusted R-squared

0.10

  

Adjusted R-squared

0.00

  

 N

523

  

N

526

  

N

535

  

Active lesion burden models

 Age

0.00

–0.09

0.93

Age

–0.18

–3.83

0.00

Age

–0.07

–1.40

0.16

 Gender

–0.01

–0.33

0.74

Gender

–0.08

–1.84

0.07

Gender

–0.04

–0.88

0.38

 Active Burden

–0.04

0.00

1.00

Active Burden

–11.72

–0.89

0.38

Active Burden

–4.71

–0.34

0.73

 CIS

–0.09

–0.81

0.42

CIS

–0.48

–4.95

0.00

CIS

–0.10

–0.99

0.32

 RR

–0.17

–1.09

0.28

RR

–0.75

–5.39

0.00

RR

–0.10

–0.67

0.50

 PMS

–0.22

–1.55

0.12

PMS

–0.73

–5.59

0.00

PMS

–0.03

–0.25

0.81

 Active X CIS

0.01

0.00

1.00

Active X CIS

2.81

0.9

0.37

Active X CIS

1.02

0.34

0.73

 Active X RR

0.01

0.00

1.00

Active X RR

11.42

0.89

0.38

Active X RR

4.56

0.34

0.73

 Active X SPMS

–0.02

–0.03

0.97

Active X SPMS

0.51

0.84

0.40

Active X SPMS

0.15

0.24

0.81

 Adjusted R-squared

–0.01

  

Adjusted R-squared

0.09

  

Adjusted R-squared

0.00

  

 N

504

  

N

505

  

N

514

  

Brain volume models

 Age

0.03

0.66

0.51

Age

–0.13

–3.12

0.00

Age

0.03

0.55

0.58

 Gender

–0.02

–0.52

0.60

Gender

0.01

0.45

0.65

Gender

–0.01

–0.32

0.75

 Brain Volume*

0.09

1.00

0.32

Brain Volume*

0.22

3.08

0.00

Brain Volume*

0.10

1.16

0.25

 White Matter Vol.

–0.01

–0.09

0.93

White Matter Vol.

0.11

1.40

0.16

White Matter Vol.

–0.10

–1.02

0.31

 CIS

0.19

0.22

0.82

CIS

0.92

1.26

0.21

CIS

0.32

0.39

0.70

 RR

–0.86

–1.13

0.26

RR

0.98

1.59

0.11

RR

–0.45

–0.60

0.55

 SPMS

0.72

0.97

0.33

SPMS

1.20

1.98

0.05

SPMS

–1.09

–1.50

0.13

 Brain Vol X CIS

–0.31

–0.57

0.57

Brain Vol X CIS

–0.61

–1.34

0.18

Brain Vol X CIS

–0.12

–0.23

0.82

 Brain Vol X RR

–0.04

–0.09

0.93

Brain Vol X RR

–1.01

–2.58

0.01

Brain Vol X RR

0.06

0.13

0.90

 Brain Vol X SPMS

–0.71

–1.47

0.14

Brain Vol X SPMS

–0.78

–1.98

0.05

Brain Vol X SPMS

–0.18

–0.38

0.70

 WMV X CIS

0.11

0.16

0.87

WMV X CIS

–0.60

–0.97

0.33

WMV X CIS

–0.25

–0.40

0.69

 WMV X RR

0.86

1.25

0.21

WMV X RR

–0.44

–0.78

0.44

WMV X RR

0.35

0.52

0.61

 WMV X SPMS

–0.12

–0.20

0.84

WMV X SPMS

–0.77

–1.60

0.11

WMV X SPMS

1.25

2.19

0.03

 Adjusted R-squared

0.01

  

Adjusted R-squared

0.28

  

Adjusted R-squared

0.00

  

 N

732

  

N

759

  

N

757

  

Subcortical gray matter volume models

 Age

0.03

0.74

0.46

Age

–0.15

–4.11

0.00

Age

–0.01

–0.19

0.85

 Gender

–0.02

–0.43

0.67

Gender

0.02

0.70

0.49

Gender

–0.01

–0.38

0.71

 Subcortical Health*

0.12

1.10

0.27

Subcortical Health*

0.35

4.01

0.00

Subcortical Health*

0.01

0.11

0.91

 Amygdala Vol.

–0.02

–0.27

0.78

Amygdala Vol.

–0.16

–2.39

0.02

Amygdala Vol.

0.06

0.81

0.42

 CIS

0.00

–0.01

1.00

CIS

0.60

1.26

0.21

CIS

–0.27

–0.45

0.65

 RR

–0.27

–0.47

0.64

RR

0.37

0.81

0.42

RR

–0.03

–0.05

0.96

 SPMS

0.37

0.72

0.47

SPMS

0.48

1.18

0.24

SPMS

0.05

0.11

0.91

 Subcortical X CIS

0.04

0.06

0.95

Subcortical X CIS

–1.03

–2.07

0.04

Subcortical X CIS

0.22

0.37

0.71

 Subcortical X RR

0.16

0.27

0.79

Subcortical X RR

–1.57

–3.43

0.00

Subcortical X RR

0.24

0.44

0.66

 Subcortical X SPMS

–0.64

–1.26

0.21

Subcortical X SPMS

–1.29

–3.12

0.00

Subcortical X SPMS

–0.03

–0.06

0.95

 Amygdala X CIS

–0.06

–0.17

0.87

Amygdala X CIS

0.15

0.52

0.61

Amygdala X CIS

–0.01

–0.04

0.97

 Amygdala X RR

0.08

0.22

0.83

Amygdala X RR

0.77

2.70

0.01

Amygdala X RR

–0.27

–0.79

0.43

 Amygdala X SPMS

0.19

0.58

0.56

Amygdala X SPMS

0.48

1.83

0.07

Amygdala X SPMS

–0.04

–0.12

0.90

 Adjusted R-squared

0.01

  

Adjusted R-squared

0.29

  

Adjusted R-squared

–0.01

  

 N

731

  

N

758

  

N

756

  
  1. CIS, Clinically Isolated Syndrome, RRMS Relapsing Remitting MS, SPMS Secondary Progressive MS
  2. aInteraction terms are denoted by “X’ between main effect terms in the bottom section of each table. The referent group is healthy controls